Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Trial Status: active

This trial studies the metabolism of kidney or urothelial cancer in patients undergoing surgical removal (resection) and/or biopsy. Metabolism is the term used to describe how cells take up different nutrients and convert them to energy and materials needed for cell growth. In cancer, metabolism is hijacked to support the needs of cancer cells. Cancer cells can use multiple nutrients in the blood to fuel their growth, but it is not yet known what materials cancer cells make with those nutrients in patients. This study may help researchers understand how kidney cancers change their metabolism to adapt, grow, and survive in patients. The researchers may use the knowledge from this study to support development of therapies that target metabolic adaptations of cancer cells, and to develop new, non-invasive imaging techniques that can be used to monitor tumor growth.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.